Literature DB >> 18797183

Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma.

Tsuyoshi Yoshimura1, Mamoru Yoshikawa, Nobuyoshi Otori, Shin-ichi Haruna, Hiroshi Moriyama.   

Abstract

BACKGROUND: The prevalence of patients with chronic rhinosinusitis (CRS) refractory to traditional therapy appears to be on the increase. In these cases, CRS tends to be associated with bronchial asthma (BA), especially, aspirin-intolerant asthma (AIA). On the other hand, arachidonic acid metabolites have been extensively investigated in the pathogenesis of BA. We sought to assess the role of prostaglandin D(2) (PGD(2)) and prostaglandin E(2) (PGE(2)) in the recalcitrant pathophysiology of CRS.
METHODS: Samples were prepared from the nasal polyps and mucosa of 40 patients undergoing endoscopic sinus surgery (ESS) at our hospital. The nasal polyp specimens obtained from the patients with CRS were divided into three groups, as follows: the CRS-AIA group, consisting of specimens obtained from patients with CRS complicated by AIA, the CRS-ATA group, consisting of specimens obtained from patients with CRS associated with aspirin-tolerant asthma (ATA), and the CRS-NA group, consisting of specimens obtained from CRS patients without BA. PGD(2) and PGE(2) were extracted from the specimens and quantified.
RESULTS: The concentrations of PGD(2) were significantly higher in the nasal polyps of the CRS-ATA group. The concentrations of PGE(2) were lowest in the nasal polyps of the CRS-AIA group. The PGD(2)/PGE(2) ratio was highest in the CRS-AIA group.
CONCLUSIONS: It has previously been reported that CRS complicated by AIA is most likely to be characterized by repeated remissions and relapses, and is thus the most intractable. We may therefore say that the PGD(2)/PGE(2) ratio reflects the intractable nature of CRS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797183     DOI: 10.2332/allergolint.o-08-545

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  28 in total

1.  Biology of nasal polyposis.

Authors:  Whitney W Stevens; Robert P Schleimer; Rakesh K Chandra; Anju T Peters
Journal:  J Allergy Clin Immunol       Date:  2014-05       Impact factor: 10.793

2.  Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation.

Authors:  Tao Liu; Tanya M Laidlaw; Chunli Feng; Wei Xing; Shiliang Shen; Ginger L Milne; Joshua A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 3.  Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations.

Authors:  Joshua M Levy; Luke Rudmik; Anju T Peters; Sarah K Wise; Brian W Rotenberg; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2016-08-02       Impact factor: 3.858

4.  Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.

Authors:  Elina Jerschow; Matthew L Edin; Yuling Chi; Beth Hurst; Waleed M Abuzeid; Nadeem A Akbar; Marc Gibber; Marvin P Fried; Weiguo Han; Teresa Pelletier; Zhen Ren; Taha Keskin; Gigia Roizen; Fred B Lih; Artiom Gruzdev; J Alyce Bradbury; Victor Schuster; Simon Spivack; David Rosenstreich; Darryl C Zeldin
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-21

5.  Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Katherine N Cahill; Howard R Katz; Katherine C Murphy; Chunli Feng; Kathleen Lee-Sarwar; Juying Lai; Neil Bhattacharyya; Elliot Israel; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2015-12-12       Impact factor: 10.793

Review 6.  Human asthma phenotypes: from the clinic, to cytokines, and back again.

Authors:  Nirav R Bhakta; Prescott G Woodruff
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

7.  Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Anya J Cutler; Molly S Kidder; Tao Liu; Juan Carlos Cardet; Heng Chhay; Chunli Feng; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

8.  Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.

Authors:  Katherine N Cahill; Jillian C Bensko; Joshua A Boyce; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2014-09-11       Impact factor: 10.793

Review 9.  Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function.

Authors:  Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2019-10       Impact factor: 10.793

Review 10.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.